| scholarly article | Q13442814 |
| P50 | author | Steven J. Norris | Q40830286 |
| Jeffrey K. Actor | Q41487064 | ||
| P2093 | author name string | Chinnaswamy Jagannath | |
| Robert L Hunter | |||
| Lisa Y Armitige | |||
| Audrey Wanger | |||
| Eliud Sepulveda | |||
| Robert H Copenhaver | |||
| P2860 | cites work | Decreased infectivity despite unaltered C3 binding by a DeltahbhA mutant of Mycobacterium tuberculosis | Q24319060 |
| Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens | Q24630289 | ||
| Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model | Q24675231 | ||
| Phospholipases C are involved in the virulence of Mycobacterium tuberculosis | Q28486439 | ||
| Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages | Q28486461 | ||
| The allele encoding the mycobacterial Erp protein affects lung disease in mice | Q28486728 | ||
| Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope | Q28486853 | ||
| Characterization of a Mycobacterium tuberculosis H37Rv transposon library reveals insertions in 351 ORFs and mutants with altered virulence | Q28486929 | ||
| Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase | Q28486974 | ||
| A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis | Q28487225 | ||
| Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis | Q28487409 | ||
| Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis | Q28487576 | ||
| Mycobacterium tuberculosis: here today, and here tomorrow | Q29619735 | ||
| Determinants of vaccine-induced resistance in animal models of pulmonary tuberculosis. | Q30328118 | ||
| Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode | Q34003715 | ||
| Silencing of oxidative stress response in Mycobacterium tuberculosis: expression patterns of ahpC in virulent and avirulent strains and effect of ahpC inactivation | Q34009146 | ||
| Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH | Q34032570 | ||
| Disruption of the gene homologous to mammalian Nramp1 in Mycobacterium tuberculosis does not affect virulence in mice | Q34128847 | ||
| Tuberculosis vaccine development: recent progress | Q34175547 | ||
| BCG: the challenge continues | Q34246761 | ||
| Tuberculosis DNA vaccines | Q34246769 | ||
| The hunt for new tuberculosis vaccines: anti-TB immunity and rational design of vaccines | Q34319155 | ||
| Cord factor (alpha,alpha-trehalose 6,6'-dimycolate) inhibits fusion between phospholipid vesicles | Q35013655 | ||
| The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis | Q35655414 | ||
| Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation | Q36370092 | ||
| Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide Synthase 2-independent defense in mice | Q36371162 | ||
| Attenuation of virulence in Mycobacterium tuberculosis expressing a constitutively active iron repressor | Q36559920 | ||
| Evaluation of the protective potency of new tuberculosis vaccines. | Q38621878 | ||
| Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis | Q39338589 | ||
| Vaccinated mice remain more susceptible to Mycobacterium tuberculosis infection initiated via the respiratory route than via the intravenous route | Q39510630 | ||
| Naive human T cells develop into Th1 effectors after stimulation with Mycobacterium tuberculosis-infected macrophages or recombinant Ag85 proteins | Q39517273 | ||
| Interleukin-1 production by mouse macrophages is regulated in a feedback fashion by nitric oxide | Q40915421 | ||
| "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms | Q42554386 | ||
| Vaccinating Properties of Avirulent Dissociates of Five Different Strains of Tubercle Bacilli | Q42624390 | ||
| Immunogenicity and protective efficacy of a tuberculosis DNA vaccine | Q44024302 | ||
| A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. | Q44130148 | ||
| A mouse model of the recrudescence of latent tuberculosis in the elderly | Q44175884 | ||
| Mycobacterial pathogenesis: a historical perspective | Q46441006 | ||
| A flash-type bioluminescent immunoassay that is more sensitive than radioimaging: quantitative detection of cytokine cDNA in activated and resting human cells | Q48001671 | ||
| Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG. | Q50121898 | ||
| Involvement of the fadD33 gene in the growth of Mycobacterium tuberculosis in the liver of BALB/c mice. | Q52548604 | ||
| Deletion of the putative antioxidant noxR1 does not alter the virulence of Mycobacterium tuberculosis H37Rv. | Q53902694 | ||
| Inactivation of the Mycobacterium tuberculosis Nramp orthologue (mntH) does not affect virulence in a mouse model of tuberculosis. | Q53977031 | ||
| Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex | Q57203149 | ||
| The mycobacterial antigens 85 complex – from structure to function and beyond: Response | Q63369545 | ||
| Mycobacterium tuberculosis Is Strikingly More Virulent for Mice When Given via the Respiratory than via the Intravenous Route | Q71829829 | ||
| Relationship of survival, organism containment, and granuloma formation in acute murine tuberculosis | Q73146285 | ||
| Enhancement of immunocompetence in tuberculosis by DNA vaccination | Q73480299 | ||
| Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion | Q73488662 | ||
| The immunogenicity of single and combination DNA vaccines against tuberculosis | Q73544810 | ||
| A role for complement C5 in organism containment and granulomatous response during murine tuberculosis | Q73773015 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| P304 | page(s) | 7084-7095 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential | |
| P478 | volume | 72 |
| Q89985551 | A novel mutation alters the stability of PapA2 resulting in the complete abrogation of sulfolipids in clinical mycobacterial strains |
| Q37188632 | A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice |
| Q37412779 | A systems biology approach to study the phagosomal proteome modulated by mycobacterial infections. |
| Q92512523 | An autophagy-inducing and TLR-2 activating BCG vaccine induces a robust protection against tuberculosis in mice |
| Q38041566 | An update on vaccines for tuberculosis - there is more to it than just waning of BCG efficacy with time |
| Q35867371 | Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis |
| Q46104296 | Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells |
| Q40321976 | Characterisation of iunH gene knockout strain from Mycobacterium tuberculosis |
| Q28087077 | Current efforts and future prospects in the development of live mycobacteria as vaccines |
| Q44676853 | Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide |
| Q36038717 | Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis |
| Q64135203 | Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs |
| Q33223435 | FbpA-Dependent biosynthesis of trehalose dimycolate is required for the intrinsic multidrug resistance, cell wall structure, and colonial morphology of Mycobacterium smegmatis |
| Q36109585 | HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology |
| Q39574791 | Label-free proteomics and systems biology analysis of mycobacterial phagosomes in dendritic cells and macrophages. |
| Q26770855 | Lactoferrin: A Modulator for Immunity against Tuberculosis Related Granulomatous Pathology |
| Q36973760 | Mycobacterial glycolipid trehalose 6,6'-dimycolate-induced hypersensitive granulomas: contribution of CD4+ lymphocytes |
| Q36277455 | Nocardia brasiliensis cell wall lipids modulate macrophage and dendritic responses that favor development of experimental actinomycetoma in BALB/c mice. |
| Q36247723 | Preclinical testing of new vaccines for tuberculosis: a comprehensive review |
| Q42257227 | Principal Component Analysis of Proteome Dynamics in Iron-starved Mycobacterium Tuberculosis |
| Q42059001 | Protein dynamics in iron-starved Mycobacterium tuberculosis revealed by turnover and abundance measurement using hybrid-linear ion trap-Fourier transform mass spectrometry |
| Q40240877 | Protein kinase C zeta plays an essential role for Mycobacterium tuberculosis-induced extracellular signal-regulated kinase 1/2 activation in monocytes/macrophages via Toll-like receptor 2. |
| Q28486937 | Protein kinase E of Mycobacterium tuberculosis has a role in the nitric oxide stress response and apoptosis in a human macrophage model of infection |
| Q35035800 | Secretory phosphatases deficient mutant of Mycobacterium tuberculosis imparts protection at the primary site of infection in guinea pigs |
| Q36929373 | TB research at UT-Houston--a review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis. |
| Q40722193 | The Ag85B protein of the BCG vaccine facilitates macrophage uptake but is dispensable for protection against aerosol Mycobacterium tuberculosis infection |
| Q33318121 | The Delta fbpA mutant derived from Mycobacterium tuberculosis H37Rv has an enhanced susceptibility to intracellular antimicrobial oxidative mechanisms, undergoes limited phagosome maturation and activates macrophages and dendritic cells |
| Q28486552 | The Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesis |
| Q34264596 | The fbpA/sapM double knock out strain of Mycobacterium tuberculosis is highly attenuated and immunogenic in macrophages |
| Q37970858 | The ins and outs of Mycobacterium tuberculosis protein export |
| Q43043113 | The ΔfbpA attenuated candidate vaccine from Mycobacterium tuberculosis, H37Rv primes for a stronger T-bet dependent Th1 immunity in mice |
| Q43893435 | Trehalose 6,6'-dimycolate--a coat to regulate tuberculosis immunopathogenesis |
Search more.